These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25659042)

  • 1. Uric acid and mild renal impairment in patients with ST-elevation myocardial infarction.
    Lazzeri C; Valente S; Chiostri M; Spini V; Angelotti P; Gensini GF
    Scand Cardiovasc J; 2015 Feb; 49(1):14-9. PubMed ID: 25659042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid in the early risk stratification of ST-elevation myocardial infarction.
    Lazzeri C; Valente S; Chiostri M; Picariello C; Gensini GF
    Intern Emerg Med; 2012 Feb; 7(1):33-9. PubMed ID: 21234713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognostic role of uric acid in patients with ST-elevation myocardial infarction and renal dysfunction.
    Lazzeri C; Valente S; Chiostri M; Gensini GF
    J Cardiovasc Med (Hagerstown); 2015 Nov; 16(11):790-4. PubMed ID: 25806469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate in the acute phase of ST-elevation myocardial infarction treated with mechanical revascularization: a single-center experience.
    Lazzeri C; Valente S; Chiostri M; Picariello C; Gensini GF
    Am J Emerg Med; 2012 Jan; 30(1):92-6. PubMed ID: 21109381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ratio of contrast volume to glomerular filtration rate predicts in-hospital and six-month mortality in patients undergoing primary angioplasty for ST-elevation myocardial infarction.
    Çiçek G; Bozbay M; Açıkgöz SK; Altay S; Uğur M; Köroğlu B; Uyarel H
    Cardiol J; 2015; 22(1):101-7. PubMed ID: 24671903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers.
    Valente S; Lazzeri C; Chiostri M; Giglioli C; Sori A; Tigli S; Gensini GF
    Int J Cardiol; 2009 Feb; 132(1):84-9. PubMed ID: 18207587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum uric acid as an independent and incremental prognostic marker in addition to N-terminal pro-B-type natriuretic peptide in patients with acute myocardial infarction.
    Bae MH; Lee JH; Lee SH; Park SH; Yang DH; Park HS; Cho Y; Jun JE; Chae SC
    Circ J; 2011; 75(6):1440-7. PubMed ID: 21498911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia predicts adverse clinical outcomes after cardiac resynchronization therapy.
    Perge P; Boros AM; Zima E; Gellér L; Merkely B; Széplaki G
    Scand Cardiovasc J; 2018 Oct; 52(5):250-255. PubMed ID: 30714413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and cardiac function for long-term (10 year) risk stratification after myocardial infarction.
    Palmer SC; Yandle TG; Frampton CM; Troughton RW; Nicholls MG; Richards AM
    Eur Heart J; 2009 Jun; 30(12):1486-94. PubMed ID: 19389787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid in-hospital changes predict mortality in patients with acute myocardial infarction.
    Lazaros G; Tsiachris D; Aznaouridis K; Vlachopoulos C; Tsioufis C; Chrysohoou C; Patialiakas A; Masoura C; Stefanadis C
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1202-9. PubMed ID: 23791297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide in acute myocardial infarction: a marker of cardio-renal interaction.
    Moltrasio M; Cosentino N; De Metrio M; Rubino M; Cabiati A; Milazzo V; Discacciati A; Marana I; Bonomi A; Veglia F; Lauri G; Marenzi G
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):803-9. PubMed ID: 26784574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience.
    Lazzeri C; Valente S; Chiostri M; Sori A; Bernardo P; Gensini GF
    Int J Cardiol; 2010 Jan; 138(2):206-9. PubMed ID: 18684529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.
    Nacak H; van Diepen M; Qureshi AR; Carrero JJ; Stijnen T; Dekker FW; Evans M
    Nephrol Dial Transplant; 2015 Dec; 30(12):2039-45. PubMed ID: 26185050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.